What is the Drug Eluting Stents Market growth?
The Drug Eluting Stents Market is expected to grow at a CAGR of 6.4% during the forecast period 2024-2031
Which region Holds a Dominant Position in the Global Drug Eluting Stents Market ?
North America Holds a Dominant Position in the Global Drug Eluting Stents Market
Who are the key players in Drug Eluting Stents Market?
Major players are Boston Scientific Corp., Abbott Laboratories, Medtronic Plc, Biotronik Inc., Johnson & Johnson, MicroPort Scientific Corporation, Cook Medical Inc., Stentys S.A., Biosensors International Group, and Terumo Corp.
How big is the Drug Eluting Stents Market ?
Global Drug Eluting Stents Market reached USD 6.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 10.2 billion by 2031.